A forward-looking series on emerging oncology therapies, molecular biomarkers, and the evolving landscape of precision medicine — hosted by a leading clinical scientist.
Dr. Lockheimer has worked as a clinical scientist in the oncology field for decades. With extensive experience spanning cancer research, molecular diagnostics, and clinical phlebotomy, she brings a uniquely integrated perspective on biomarker-driven care and the critical role of clinical trials in advancing patient outcomes.
Evidence-based perspectives on the latest advances in oncology treatment protocols and trial outcomes.
Engage directly with Dr. Lockheimer in an open forum format designed for clinical and scientific professionals.
Take-away frameworks for integrating biomarker testing and clinical trial referrals into practice.